Open AccessIncidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort
Author(s) -
Marcelo M. Pinheiro,
Gecilmara Salviato Pileggi,
Adriana Maria Kakehasi,
Ana Reis,
Edgard Torres dos Reis-Neto,
Mirhelen Mendes de Abreu,
Cleandro Pires de Albuquerque,
Nafice Costa Araújo,
Ana Beatriz Santos Bacchiega,
Dante Valdetaro Bianchi,
B. Bica,
Eloísa Bonfá,
Eduardo F. Borba,
Danielle Christinne Soares Egypto de Brito,
Débora Cerqueira Calderaro,
Ana Maria Tavares Duarte,
R.C.E. Cavalheiro Do Espírito Santo,
Paula Reale Fernandes,
Mariana Peixoto Guimarães,
Kirla Wagner Poti Gomes,
G. G. Faustino Ilana,
Evandro Mendes Klumb,
C. Marques,
Ana Karla Guedes de Melo,
Odirlei André Monticielo,
Lícia Maria Henrique da Mota,
Gabriela Araújo Munhoz,
Eduardo S. Paiva,
Helena Lúcia Alves Pereira,
José Roberto Provenza,
Sandra Lúcia Euzébio Ribeiro,
Laurindo Ferreira da Rocha,
Emília Inoue Sato,
Thelma Skare,
Viviane Angelina de Souza,
Valéria Valim,
Marcus Vinícius Guimarães Lacerda,
Ricardo Machado Xavier,
Gilda Aparecida Ferreira
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/67oyux
Subject(s) - medicine , hydroxychloroquine , incidence (geometry) , covid-19 , prospective cohort study , epidemiology , cohort , cohort study , disease , physics , infectious disease (medical specialty) , optics
To evaluate the incidence of COVID-19 and its main outcomes in rheumatic disease (RD) patients on hydroxychloroquine (HCQ) compared to household cohabitants (HC).